Journal article icon

Journal article

Controlled trial of budesonide–formoterol as needed for mild asthma

Abstract:

BACKGROUND

In double-blind, placebo-controlled trials, budesonide–formoterol used on an as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed use of a short-acting β2-agonist (SABA); the risk was similar to that of budesonide maintenance therapy plus as-needed SABA. The availability of data from clinical trials designed to better reflect clinical practice would be beneficial.

METHODS

We conducted a 52-week, randomized, open-label, par...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1056/nejmoa1901963

Authors


More by this author
Role:
Author
ORCID:
0000-0003-0337-406X
More by this author
Role:
Author
ORCID:
0000-0001-5327-3027
Expand authors...
Publisher:
Massachusetts Medical Society Publisher's website
Journal:
New England Journal of Medicine Journal website
Volume:
380
Issue:
21
Pages:
2020-2030
Publication date:
2019-05-19
Acceptance date:
2019-04-05
DOI:
EISSN:
1533-4406
ISSN:
0028-4793
Pmid:
31112386
Source identifiers:
1004158
Language:
English
Pubs id:
pubs:1004158
UUID:
uuid:51972817-1b8a-4a46-8838-c33827e0ffa0
Local pid:
pubs:1004158
Deposit date:
2019-06-24

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP